DiagnoCure Inc. announced earnings results for the second quarter ended April 30, 2014. For the quarter, the company reported license and royalty revenues of $130,493 compared to $164,262 a year ago. Total revenues were $130,493 compared to $164,262 a year ago.

Net loss (before stock-based compensation, depreciation and amortization) was $431,706 compared to $609,780 a year ago. Net loss and comprehensive loss was $536,597 or $0.01 per basic and diluted share compared to $849,344 or $0.02 per basic and diluted share a year ago. The decrease in revenue was $33,769 or 21% is attributable to PCA3 royalties, reflecting a reduction of 32% in U.S. royalty revenues and an increase of 1% in European royalty revenues as compared to the same period in 2013.